Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
EVENT DATES
Jun 2018
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
252627282930 
EXHIBITION HALL DATES
Jun 2018
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
252627282930 

Venue

Boston Convention & Exhibition Center 415 Summer St Boston , Massachusetts 02210
Tel: (617) 954-2000
Website
Google Map

DIA 2018 Annual Meeting - Drug Information Association

Attendees

6,000

Exhibitors

400

Register

$1,019 - $1,989

Overview

Event Overview:

The DIA Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. DIA 2018 will host more than 7,000 global health care professionals in the pharmaceutical, biotechnology, and medical device communities from more than 51 countries. DIA 2018 will hold more than 160 sessions over 10+ tracks and bring in more than 450 exhibiting companies.

DIA Annual Meeting will:

  • Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
  • Provide comprehensive coverage of the full development and life cycle management of process for all health care products
  • Offer a holistic and integrated approach to the development life cycle management of regulated health care products

 

About Exhibits

Join DIA for the largest multidisciplinary event that brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

Attendee Information:

DIA 2018 provides an invaluable forum for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related medical products.

DIA Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Who Should Attend?

This meeting is designed for individuals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related medical products. The Annual Meeting is intended to strengthen professionals’ understanding of the value of cross-discipline integration and to foster innovation for better health outcomes.

Exhibitor Information:

Reach Your Audience
At DIA conferences, medical product developers, regulators, academics, and patient advocates all come together in one place, eager to receive fresh insight and share new information. DIA conferences are the perfect place for you to communicate your key messages to an influential audience, efficiently and cost effectively.

Join DIA and an anticipated 7,000+ attendees for the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

DIA 2018 provides an invaluable forum for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related medical products.

WHY EXHIBIT?
Showcase your products and services
Connect with key decision-makers from around the globe
Reinforce your brand influence within the health care product development industry
Gather high-quality leads to foster new business for your company

About DIA:

For more than 50 years, DIA (the Drug Information Association) has served as a global forum for all those involved in health care product development and life cycle management to exchange knowledge and collaborate in a neutral setting. DIA is an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.

Exhibitor Prospectus and Kit

Keynote Speakers

Nora D. Volkow, MD

All Hands on Deck: Using Science to Help Solve the Opioid Crisis

Every day, more than 115 Americans die after overdosing on opioids. The misuse of and addiction to opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious national crisis that affects public health as well as social and economic welfare. The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse alone in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.  

Yet the need for pain management therapies is great. More than 25 million Americans suffer from chronic pain and are in need of therapies to manage it. As the Director of the National Institute on Drug Abuse (NIDA) at NIH, Dr. Nora Volkow will present her vision for therapeutics and devices in pain modulation and opioid addiction, with a focus on developing better overdose-reversal and prevention interventions to reduce mortality, saving lives for future treatment and recovery; finding new, innovative medications and technologies to treat opioid addiction; and finding safe, effective, non-addictive interventions to manage chronic pain. Public-private partnerships will play a key role in meeting these challenges through the development of new technologies, regulatory science, and exploratory basic research. 

Dr. Volkow will discuss the need for development of new molecules and formulations, technologies for stimulation of the brain and neurocircuitry, advances in biofeedback, and unique opportunities for wireless and mobile technologies to assist in pain management. She will also emphasize the importance of public-private partnerships in addressing these issues and how to get involved.

"In order for us to be successful in our mission, which is to bring the power of knowledge into solutions for the prevention and treatment of substance abuse disorders, for us to succeed, we have to partner with multiple institutions…Being able to bring that knowledge into practice requires collaboration."

Nora D. Volkow, MD, became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction.

Dr. Volkow’s work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.

Dr. Volkow was born in Mexico, attended the Modern American School, and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned the Laughlin Fellowship Award as one of the 10 Outstanding Psychiatric Residents in the USA.

Dr. Volkow spent most of her professional career at the Department of Energy’s Brookhaven National Laboratory (BNL) in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Dr. Volkow was a Professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York (SUNY)-Stony Brook.

Dr. Volkow has published more than 680 peer-reviewed articles and written more than 100 book chapters and non-peer-reviewed manuscripts, and has also edited four books on neuroimaging for mental and addictive disorders.

During her professional career, Dr. Volkow has been the recipient of multiple awards. In 2013, she was a Samuel J. Heyman Service to America Medal (Sammies) finalist and was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was elected to membership in the Institute of Medicine in the National Academy of Sciences, received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science, and was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University. She has been named one of Time magazine’s “Top 100 People Who Shape Our World”, “One of the 20 People to Watch” by Newsweek magazine, Washingtonian magazine’s “100 Most Powerful Women” in both 2015 and 2017, “Innovator of the Year” by U.S. News & World Report, and one of “34 Leaders Who Are Changing Health Care” by Fortune magazine. Dr. Volkow was the subject of a 2012 profile piece by CBS’s 60 Minutes and was a featured speaker at TEDMED 2014.

SERVICE PROVIDERS

HOTELS NEARBY

MORE events +

I Want to


CURRENTS is an excellent way to personally connect with 350+ attendees for optimum exposure. Take advantage of our exhibitor packages for maximum ROI.
Send me discounts and offers from hotels nearby
By Signing up you agree to User Agreement and Privacy Policy
I want to list my services